Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Leukemia Research|July 1, 2008
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximabClive S Zent, Charla R Secreto, Betsy R LaPlant, et al.
Leukemia & Lymphoma|November 30, 2013
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphomaMichael J Conte, Deborah A Bowen, Gregory A Wiseman, et al.
Leukemia Research|July 29, 2008
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaTait D Shanafelt, Deborah A Bowen, Chaya Venkat, et al.
Cancer|December 18, 2008
Validation of a new prognostic index for patients with chronic lymphocytic leukemiaTait D Shanafelt, Greg Jenkins, Timothy G Call, et al.
Leukemia & Lymphoma|March 23, 2010
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneDeborah A Bowen, Timothy G Call, Tait D Shanafelt, et al.
Leukemia & Lymphoma|December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic featuresDeborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.
International Journal of Cancer|March 1, 2021
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphomaMark Liebow, Melissa C Larson, Carrie A Thompson, et al.
Expert Review of Hematology|February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemiaNeil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.
Pageof 18